4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-17-000632
Chief Scientific Officer gave up 23,968 shares (to pay taxes)
- Chief Scientific Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Erlander Mark · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-01-02 | Exercise or conversion : show line 1 in the form | +50,000 | 55,000 | D |
| 2017-01-02 | Shares withheld for taxes : show line 2 in the form | −23,968 | 31,032 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-01-02 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −50,000 | 0 | D |
| 2017-01-02 | Grant or award : show line 4 in the form Restricted Stock Units | +30,001 | 30,001 | D |
| 2017-01-02 | Grant or award : show line 5 in the form Restricted Stock Units | +75,000 | 105,001 | D |
Loading xslF345X03/a4.xml…